Retail clinics brought grocery-aisle convenience to strep tests and flu shots. Now they're aiming to manage chronic conditions.
There's an exceptionally long list of possible causes for multiple sclerosis, and growing evidence that almost all may play a role.
Zinc fingers could pull gene therapy back from the brink—but only if more researchers can get their hands on the remarkable proteins.
Untouchable for decades, hallucinogenic drugs are back in the lab, with new research into how they work and what they might achieve.
Peter L. Slavin and David F. Torchiana suggest an updated approach to intellectual property rights to optimize innovation.
Proto readers opine on the effectiveness of physician recertification, Judith Warner’s take on medicating children, stemming a brain drain and reversing blindness.
A strain of the sometimes-deadly bacteria is defying antibiotics.
A pioneer in meditation reflects on the past and future of research into the mind body connection.
For some patients, doctors provide the cause of, not the cure for, high blood pressure.
Will the next edition of the definitive guide to assessing mental health be too broad?
Thomas Hunt Morgan's discoveries won him the Nobel Prize and forever altered American Laboratories.
A federal court recently ruled that they couldn't, whereas supporters and critics continue to debate whether patents foster or hinder innovation.
High-tech mannequins and simulation software are becoming more prevalent in medical schools.
Genetic tests can be fraught with false positives and insignificant findings that may undermine their effectiveness.
For one woman, a scar left behind by her husband's cancer treatment isn't a disfigurement, but a mark of survival.